research Some thoughts: Scattered hair and there!
Dr. Shyam B Verma encourages more scientific research on hair disorders and criticizes the unscientific hair care market in India.
Search
forResearch
5 / 1000+ resultsresearch Hair India 2010
The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.
research Meeting report: The 15thannual meeting of the European hair research society
The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.
research Controversy: Synthetic hairs and their role in hair restoration?
This article reviews the use of artificial hair fibers, discussing their controversial history and the FDA ban, and reports no new research findings.
research Highlights of Hair India 2012
Hair India 2012 was a successful international event focused on combating fake trichology practices and discussing various hair health topics.
Community Join
5 / 1000+ resultscommunity Anyone here have a lot of knowledge on hair follicle stem cells and progenitor cells for PP405?
Hair follicle stem cells remain in bald individuals, but progenitor cells do not, raising questions about hair regrowth claims by Pelage. PP405 is discussed as a potential treatment, with skepticism about its effectiveness compared to existing treatments like Minoxidil and Finasteride.
community Recent (April 2025) study directly addressing whether creatine use causes hair loss (it doesn't)
Creatine does not cause hair loss, but it may accelerate it in those predisposed to male pattern baldness. The study suggests that creatine does not affect DHT or hair loss, but individual reactions may vary.
community I think I’ve finally found the reason for my hair loss
The user experienced hair loss since 2019 and tried finasteride, dutasteride, RU58841, and ketoconazole shampoo without success. A scalp biopsy showed scarring and inflammation from folliculitis, indicating chronic inflammation was affecting treatment effectiveness.
community Haircafe on why microneedling is bad for hair growth
Microneedling combined with minoxidil and finasteride shows significant hair regrowth, though opinions on its effectiveness vary. Some users report substantial benefits, while others highlight the need for more research and consistency in application.
community Genomic Sequencing for Hair Loss
Hair loss treatments like Minoxidil, finasteride, and potential mRNA therapies are discussed. There is skepticism about targeting specific genes due to the complex genetic nature of hair loss.
Learn
5 / 801 results- What side effects or limitations have been reported with Setipiprant use in hair loss research? In the one published hair-loss trial (DuBois 2021, 169 men, 24 weeks), setipiprant produced no significant hair regrowth over placebo. Treatment-related side effects — mostly mild headaches, stomach upset and fatigue — were reported in about a quarter of the setipiprant group versus just over twelve percent on placebo, and no serious events were attributed to the drug. It is an unapproved, experimental compound with no long-term safety data.
- How does tofacitinib differ when used orally versus topically in hair loss treatment research? Oral tofacitinib acts on immune signalling throughout the body and has the stronger regrowth evidence in alopecia areata, alongside an FDA boxed warning; topical tofacitinib aims to act only on the scalp, but the human evidence is a handful of small compounded-formulation studies with no large randomized trial. Neither route is approved for hair loss, and regrowth generally reverses after treatment stops.
- What types of alopecia or hair loss conditions might TDM-105795 be designed to target based on current research? TDM-105795 may target non-scarring alopecia, particularly androgenetic alopecia.
- What should users understand about the distinction between medical research and consumer hair products involving valproic acid? Valproic acid is a prescription drug, not a cosmetic ingredient for hair loss.
- Kintor Pharmaceutical: KX-826, a New Name in Hair Loss Research KX-826 (pyrilutamide) is an experimental topical androgen receptor blocker from Kintor Pharmaceutical. It is not approved as a medicine anywhere; the company reports that its China Phase III trial met its primary endpoint at 24 weeks, but the trial data has been released through corporate announcements rather than peer-reviewed journals and long-term safety is unknown.
learn Setipiprant
learn Tofacitinib
learn TDM-105795
learn Valproic acid
learn KX-826
Clinics
6 / 13 results
Hair SystemsAlopecia Hair SocietyDuluth, GA · US- Hair TransplantHair Loss TreatmentsSMPInternational Society of Hair Restoration SurgeryElgin, IL · US
Hair Loss TreatmentsTrichologyWorld Trichology SocietyStaten Island, NY · US- SMPHigh Brow SocietyMiami, FL · US
- TrichologyInternational Trichology SocietyLondon, England · GB
- TrichologyThe Trichological SocietyRomford, England · GB
Experts
— no results